journal article·2022-12Open access

Extracellular Matrix Modulates Outgrowth Dynamics in Ovarian Cancer

Sarah Alshehri, Tonja Pavlovič, Sadaf Farsinejad, Panteha Behboodi, Li Quan, Daniel Centeno, Douglas Kung, Marta Rezler, Woo Lee, Piotr Jasiński, Elżbieta Dziabaszewska, Ewa Nowak‐Markwitz, Dilhan Kalyon, Mikołaj P. Zaborowski, Marcin Iwanicki

Advanced Biology· Volume 6· Issue 12

Abstract

Abstract Ovarian carcinoma (OC) forms outgrowths that extend from the outer surface of an afflicted organ into the peritoneum. OC outgrowth formation is poorly understood due to the limited availability of cell culture models examining the behavior of cells that form outgrowths. Prompted by immunochemical evaluation of extracellular matrix (ECM) components in human tissues, laminin and collagen‐rich ECM‐reconstituted cell culture models amenable to studies of cell clusters that can form outgrowths are developed. It is demonstrated that ECM promotes outgrowth formation in fallopian tube non‐ciliated epithelial cells (FNE) expressing mutant p53 and various OC cell lines. Outgrowths are initiated by cells that underwent outward translocation and retained the ability to intercalate into mesothelial cell monolayers. Electron microscopy, optical coherence tomography, and small amplitude oscillatory shear experiments reveal that increased ECM levels led to increased fibrous network thickness and high shear elasticity of the microenvironment. These physical characteristics are associated with outgrowth suppression. The low ECM microenvironment mimicks the viscoelasticity of malignant peritoneal fluid (ascites) and supports cell proliferation, cell translocation, and outgrowth formation. These results highlight the importance of the ECM microenvironment in modulating OC growth and can provide additional insights into the mode of dissemination of primary and recurrent ovarian tumors.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Ovarian cancer diagnosis and treatment · Endometriosis Research and Treatment · Uterine Myomas and Treatments

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry and Chemical Biology Stevens Institute of Technology 1 Castle Point Terrace Hoboken NJ 07030 USA

Department of Chemical Engineering Stevens Institute of Technology 1 Castle Point Terrace Hoboken NJ 07030 USA

Poznań University of Medical Sciences Collegium Maius, Fredry 10 Poznań 61‐701 Poland

Department of Pathology Poznań University of Medical Sciences Polna 33 Poznań 60‐535 Poland

Department of Gynecology Obstetrics and Gynecologic Oncology Poznań University of Medical Sciences Polna 33 Poznań 60‐535 Poland

References (65)

Show source-provided references
1. 10.1097/PAS.0b013e3181cf3d7910.1097/PAS.0b013e3181cf3d79 ↗
2. 10.1016/j.ygyno.2013.03.02110.1016/j.ygyno.2013.03.021 ↗
3. 10.1016/j.ygyno.2008.01.01210.1016/j.ygyno.2008.01.012 ↗
4. 10.1038/modpathol.2016.23810.1038/modpathol.2016.238 ↗
5. 10.1155/2010/93237110.1155/2010/932371 ↗
6. 10.2353/ajpath.2010.10010510.2353/ajpath.2010.100105 ↗
7. 10.3389/fonc.2013.0025610.3389/fonc.2013.00256 ↗
8. 10.1172/jci.insight.8682910.1172/jci.insight.86829 ↗
9. 10.1016/j.jdermsci.2014.12.00310.1016/j.jdermsci.2014.12.003 ↗
10. 10.1016/j.sbi.2019.01.01510.1016/j.sbi.2019.01.015 ↗
11. 10.1152/ajprenal.00015.200410.1152/ajprenal.00015.2004 ↗
12. 10.1146/annurev.bioeng.6.040803.14004010.1146/annurev.bioeng.6.040803.140040 ↗
13. 10.1016/j.devcel.2005.12.00610.1016/j.devcel.2005.12.006 ↗
14. 10.1016/j.matbio.2019.10.00110.1016/j.matbio.2019.10.001 ↗
15. 10.1016/S0021-9290(02)00442-610.1016/S0021-9290(02)00442-6 ↗
16. 10.1042/BST036022910.1042/BST0360229 ↗
17. 10.1016/S0968-0004(00)01605-410.1016/S0968-0004(00)01605-4 ↗
18. 10.1038/s41598-019-55844-x10.1038/s41598-019-55844-x ↗
19. 10.1242/dev.129.11.271110.1242/dev.129.11.2711 ↗
20. 10.1073/pnas.181744211610.1073/pnas.1817442116 ↗
21. 10.1038/s41467-020-18794-x10.1038/s41467-020-18794-x ↗
22. 10.1097/PAS.0b013e31825ec07a10.1097/PAS.0b013e31825ec07a ↗
23. 10.3390/cancers1111180510.3390/cancers11111805 ↗
24. 10.1016/j.addr.2014.06.00510.1016/j.addr.2014.06.005 ↗
25. 10.1007/978-1-62703-125-7_1410.1007/978-1-62703-125-7_14 ↗
26. 10.3390/cancers1112195710.3390/cancers11121957 ↗
27. 10.1016/j.ccr.2011.12.02410.1016/j.ccr.2011.12.024 ↗
28. 10.1038/s41467-019-13116-210.1038/s41467-019-13116-2 ↗
29. 10.1158/2159-8290.CD-20-045510.1158/2159-8290.CD-20-0455 ↗
30. 10.1158/2159-8290.CD-18-047410.1158/2159-8290.CD-18-0474 ↗
31. 10.15252/embj.201910401310.15252/embj.2019104013 ↗
32. 10.1038/ng.357310.1038/ng.3573 ↗
33. 10.3390/biomedicines809034310.3390/biomedicines8090343 ↗
34. 10.1369/002215541771854110.1369/0022155417718541 ↗
35. 10.1021/bi00350a00510.1021/bi00350a005 ↗
36. 10.1016/S0065-3233(08)60374-510.1016/S0065-3233(08)60374-5 ↗
37. 10.1038/s41578-020-0199-810.1038/s41578-020-0199-8 ↗
38. 10.1038/ncomms312610.1038/ncomms3126 ↗
39. Davidowitz R. A. · JoVE · 2012 · e3888
40. 10.1158/2159-8274.CD-11-001010.1158/2159-8274.CD-11-0010 ↗
41. 10.1007/978-1-4899-1863-5_910.1007/978-1-4899-1863-5_9 ↗
42. 10.3389/fphy.2020.57916810.3389/fphy.2020.579168 ↗
43. 10.1016/j.semcdb.2018.05.02710.1016/j.semcdb.2018.05.027 ↗
44. 10.4161/cam.2282610.4161/cam.22826 ↗
45. 10.1101/cshperspect.a00491110.1101/cshperspect.a004911 ↗
46. 10.1038/s41586-020-2264-210.1038/s41586-020-2264-2 ↗
47. 10.1016/j.isci.2021.10267410.1016/j.isci.2021.102674 ↗
48. 10.1021/bm070091t10.1021/bm070091t ↗
49. 10.1038/srep1458010.1038/srep14580 ↗
50. 10.1002/jbm.b.3145010.1002/jbm.b.31450 ↗
51. 10.1096/fj.201900131R10.1096/fj.201900131R ↗
52. 10.1038/s41598-018-30683-410.1038/s41598-018-30683-4 ↗
53. 10.1038/385537a010.1038/385537a0 ↗
54. 10.1038/ncb0402-e9710.1038/ncb0402-e97 ↗
55. 10.1038/s41586-020-2612-210.1038/s41586-020-2612-2 ↗
56. 10.1038/nmat400910.1038/nmat4009 ↗
57. 10.1016/0304-3835(94)03625-S10.1016/0304-3835(94)03625-S ↗
58. 10.1016/j.celrep.2019.12.03410.1016/j.celrep.2019.12.034 ↗
59. 10.1016/j.ccr.2007.06.01310.1016/j.ccr.2007.06.013 ↗
60. Uphoff C. C. · 2013 · 1
61. 10.3390/biomedicines809034310.3390/biomedicines8090343 ↗
62. 10.1038/nmeth.201910.1038/nmeth.2019 ↗
63. 10.1117/1.JBO.19.2.02110210.1117/1.JBO.19.2.021102 ↗
64. 10.1016/j.ymeth.2016.09.01610.1016/j.ymeth.2016.09.016 ↗
65. 10.1371/journal.pone.017016510.1371/journal.pone.0170165 ↗